Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
|
0 |
|
|
|
Triple-Negative Breast Cancer Finding
|
phenotype |
|
Finding
|
1
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
Pancreatic Neoplasm
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
764
|
20
|
0.100 |
None |
|
0 |
|
|
|
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
1
|
|
|
Abnormality of the fallopian tube
|
phenotype |
|
Anatomical Abnormality
|
22
|
|
0.100 |
None |
|
0 |
|
|
|
Clear cell adenocarcinoma of ovary
|
disease |
Neoplasms
|
Neoplastic Process
|
30
|
2
|
0.300 |
None |
|
0 |
|
|
|
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.100 |
None |
|
0 |
|
|
|
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.100 |
None |
|
0 |
|
|
|
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
|
0 |
|
|
|
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
1.000 |
limited |
0.896 |
67 |
74
|
1996 |
2020 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.500 |
None |
0.860 |
50 |
8
|
1996 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.972 |
36 |
1
|
1996 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.200 |
None |
0.875 |
16 |
2
|
1998 |
2019 |
Uterine Cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
54
|
4
|
0.320 |
None |
1.000 |
2 |
1
|
1998 |
2006 |
Precancerous Conditions
|
group |
Neoplasms
|
Neoplastic Process
|
471
|
18
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Breast Cancer, Familial
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
183
|
91
|
0.350 |
definitive |
0.938 |
16 |
4
|
2001 |
2019 |
Hereditary Nonpolyposis Colorectal Cancer
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms; Nutritional and Metabolic Diseases
|
Neoplastic Process
|
174
|
1331
|
0.300 |
limited |
1.000 |
4 |
|
2001 |
2016 |
Colorectal cancer, hereditary nonpolyposis, type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms; Nutritional and Metabolic Diseases
|
Neoplastic Process
|
24
|
179
|
0.300 |
limited |
1.000 |
4 |
|
2001 |
2016 |
Hereditary Nonpolyposis Colorectal Neoplasms
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms; Nutritional and Metabolic Diseases
|
Neoplastic Process
|
40
|
875
|
0.300 |
limited |
1.000 |
4 |
|
2001 |
2016 |
Hereditary non-polyposis colorectal cancer syndrome
|
disease |
|
Congenital Abnormality
|
31
|
|
0.300 |
limited |
1.000 |
4 |
|
2001 |
2016 |
Hereditary Non-Polyposis Colon Cancer Type 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
23
|
154
|
0.300 |
limited |
1.000 |
4 |
|
2001 |
2016 |
Ischemic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1159
|
704
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.100 |
None |
0.833 |
18 |
1
|
2002 |
2019 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.100 |
None |
0.867 |
15 |
1
|
2002 |
2019 |